» Articles » PMID: 33434725

Disrupted Sensorimotor Gating in First-episode Psychosis Patients is Not Affected by Short-term Antipsychotic Treatment

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2021 Jan 12
PMID 33434725
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Impaired sensorimotor gating, commonly measured as disrupted prepulse inhibition (PPI) of the acoustic startle response, has been widely observed in psychotic diseases. However, most PPI studies published so far involve patients with long illness duration and different drug treatments. Few studies have investigated untreated patients at their first episode of psychotic symptoms.

Method: PPI is an acoustic startle paradigm (30, 60-, 120-ms interstimulus intervals). Startle reactivity and habituation were succesfully assessed in 49 antipsychotic-naïve first-episode psychosis (FEP) patients and compared with 35 age- and gender-matched healthy control subjects. Mean age of patients was 28 years and 27 for controls. Patients treated with antipsychotics more than 30 days were not included in the study and twenty-three out of forty-nine patients received antipsychotic treatment with a mean treatment time of 13 days.

Results: PPI was significantly lower in FEP patients, compared to healthy controls. The PPI deficiency found in these patients was not due to antipsychotic treatment since PPI did not differ between treated (n=23) and untreated patients n=(26). By using the latent curve modeling we identified a delayed habituation in patients treated with antipsychotics, suggesting that antipsychotic treatment should be considered as a confound when investigating habituation in schizophrenia.

Conclusions: Our results suggest that acute pharmacological treatment does not normalize PPI in FEP patients but should be considered as a confound when investigating habituation in these patients.

Citing Articles

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia.

Gracias J, Orhan F, Horbeck E, Holmen-Larsson J, Khanlarkani N, Malwade S Nat Commun. 2022; 13(1):6427.

PMID: 36329007 PMC: 9633609. DOI: 10.1038/s41467-022-33797-6.


Developmental Manipulation-Induced Changes in Cognitive Functioning.

Kaki S, DeRosa H, Timmerman B, Brummelte S, Hunter R, Kentner A Curr Top Behav Neurosci. 2022; 63:241-289.

PMID: 36029460 PMC: 9971379. DOI: 10.1007/7854_2022_389.


The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease.

Jimenez H, Adrien L, Wolin A, Eun J, Chang E, Burstein E Alzheimers Dement (N Y). 2022; 8(1):e12247.

PMID: 35128032 PMC: 8804623. DOI: 10.1002/trc2.12247.